Drug Trial Radar · NCT07289776
A First-in-human Trial of GRT7041 in Healthy Participants
Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jan 14, 2026
Primary completion
Aug 24, 2026
Study completion Aug 28, 2026
Sponsor
- Lead sponsor
- Grünenthal GmbHIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this trial is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of GRT7041 in healthy male and female (Women of non-childbearing potential) participants. The trial duration will be up to approximately 6 weeks for participants in Part 1 (Single ascending dose \[SAD\]), except for participants taking part in the food effect cohort SAD3 where the trial duration will be up to approximately 8 weeks. The trial duration will be up to approximately 7 weeks in Part 2 (Multiple ascending dose \[MAD\]), and the Treatment Period will be up to 14 days (for Part 2). The trial will include a Screening Visit, an in-house stay period and Follow-up (FU) Visit/End-of-Trial (EoT) Visit.
Conditions
- Treatment of Pain
Interventions
GRT7041 SADDrug
Single ascending doses
PlaceboDrug
Placebo to match GRT7041 dose strength
MidazolamDrug
Solution
GRT7041 MADDrug
Multiple ascending doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Adverse EventsTime frame: Through study completion, an average of 8 Weeks
- Number of participants with Serious Adverse EventsTime frame: Through study completion, an average of 8 Weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
New Zealand Clinical Research (NZCR)
Christchurch, New Zealand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.